AI Verdict
NABL has stronger fundamentals based on our AI analysis.
NAMSW vs NABL Fundamental Comparison
| Metric | NAMSW | NABL |
|---|---|---|
| Revenue | $22.5M | $511.4M |
| Net Income | $-203.8M | $-17.0M |
| Net Margin | -905.7% | -3.3% |
| ROE | -29.8% | -2.1% |
| ROA | -26.5% | -1.2% |
| Current Ratio | 7.88x | 1.19x |
| Debt/Equity | 0.00x | 0.49x |
| EPS | $-1.72 | $-0.09 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
NAMSW vs NABL: Frequently Asked Questions
Is NAMSW or NABL a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), NABL has stronger fundamentals. NAMSW is rated STRONG SELL (88% confidence) while NABL is rated HOLD (70% confidence). This is not investment advice.
How does NAMSW compare to NABL fundamentally?
NewAmsterdam Pharma Co N.V. has ROE of -29.8% vs N-able, Inc.'s -2.1%. Net margins are -905.7% vs -3.3% respectively.
Which stock pays higher dividends, NAMSW or NABL?
NAMSW has a dividend yield of N/A or no dividend while NABL has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in NAMSW or NABL for long term?
For long-term investing, consider that NAMSW has STRONG SELL rating with 88% confidence, while NABL has HOLD rating with 70% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about NAMSW vs NABL?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For NAMSW vs NABL, the AI consensus favors NABL based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.